Table of contents:
1. The impact of genomics/ribonomics/proteomics on autoantigen and autoantibody research
Using messenger RNP autoantibodies to reveal networks of posttranscriptional operons
J. Keene, S. A. Tenenbaum
Modern techniques in mass spectrometry based proteomics
M. Mann, J. Andersen, Y. Ishihama, J. Rappsilber, S. Ong, L. Foster, B. Blagoev, I. Kratchmarova, E. Lasonder
The use of phage display to identify a conformational autoepitope in primary biliary cirrhosis
M. Scealy, I.R. Mackay, M.J. Rowley
Anti-citrulline antibodies and citrullinating enzymes in RA
E. R. Vossenaar, T. Radstake, A. van der Heijden, P. Barrera, G. Pruijn, W. J. van Venrooij
A study of overlapping epitopes recognised by antibodies to GAD65 using phage display
K. H. O'Connor, M. Scealy, M. J. Rowley
Epitope-fine mapping of the major C-terminal epitope of the ribosomal P- proteins
M. Mahler, K. Kessenbrock, J. Raats, M. Blüthner
2. New diagnostic techniques in autoantigen/autoantibody analyses
New technologies in the detection of autoantibodies: The present and future
M. Fritzler
Systematic analyses of microbial antigens and infection induced autoimmunity
P. Krebs, B. Ludewig, B. Metters, O. Türeci, R. M. Zinkernagel, H. Hengartner, U. Sahin
Line-assay with recombinant antigens for diagnosis of systemic autoimmune rheumatic diseases
T. Kattenfeld, A. Kromminga, M. Motz
Three multiplexed tests for extractable nuclear antigens using the Luminex 100
R. W. Burlingame, A. L. Piette, C. von Mühlen, K. M. Pollard, W. L. Binder
The BIOONE(r) system: the new dosage of autoantibodies
L. Voorn, P. Backelandt, A. Duyckaerts, L. Zecchinon, T. Swiatkowski, A. Bosseloir
Automatized classification of HEp-2-cell based indirect immunofluorescence patterns by a novel computerized system
U. Sack, S. Knöchner, P. Perner, U. Pigla, M. Kamprad
Simple and sensitive detection of serum autoantibodies to full-length bullous pemphigoid antigen 180
E. Schmidt, A. Kromminga, D. Zillikens, U. Zimmermann
Rapid flow cytometric differentiation of anti-platelet antibodies with microspheres
M. Woetzel, S. Schroeder, U. Sack, F. Emmrich
3. Novel autoantibodies of diagnostic and / or pathogenic relevance
Novel cytoplasmic mRNP compartment recognized by human autoantibodies
E. K. L. Chan
Autoimmune response to glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) is strongly associated with its cellular function in lupus patients
Y. Takasaki, K. Kaneda, H. Yamada, M. Nawata, K. Ikeda, M. Matsushita, R. Matsudairav, K. Takeuchi, N. Shindo, K. Murayama, H. Hashimoto
Translational regulators as autoantigens in systemic autoimmune diseases
G. Steiner, K. Skriner, G. Fabini, E. Jimenez-Boj, N. Kedersha, C. Zimmermann, M. Tohidast-Akrad, G. Schett, R. Fritsch, E. Höfler, P. Anderson, J. Smolen
Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations
H. van Eenennaam, J. H. P. Vogelzangs, L. Bisschops, L. C. J. te Boome, H. P. Seelig, M. Renz, D.-J. de Rooij, R. Brouwer, H. P. Pluk, W. J. van Venrooij, F. H. J. van den Hoogen, G. J. M. Pruijn
Prevalence of Antibodies against Alpha-Fodrin in Sjögren´s syndrome: Comparison of two Sets of Classification Criteria
T. Witte, T. Matthias, M. Oppermann, K. Helmke, H. H. Peter, R. E. Schmidt, M. Tishler
New antibody pattern in liver transplant patients with genetic donor-recipient incompatibility for GSTT1 - Correlation with de novo-immune mediated hepatitis and monoclonal gammopathy
I. Wichmann, I. Aguilera, J. M. Sousa, A. Bernardos, E. Franco, J. R. García-Lozano, A. Núñez-Roldßn
Identification and molecular characterization of two autoantibody systems associated with the indirect immunofluorescence cytoplasm discrete speckled (IIF-CDS) pattern
C. C. F. C. Laurino, N. P. Silva, A. H. Straus, H. K. Takahashi, M. Benchimol, I. C. Almeida, R. Mortara, R. Tedesco, L. E. C. Andrade
NY-ESO1 autoantibody - a novel candidate for early diagnosis of lung cancer
K. Conrad, P. Krause, O. Türeci, W. Heine, U. Luxemburger, J. Mehlhorn, U. Sahin
Antibodies recognizing different retinal antigens are present in sera of patients with lung diseases
W. A. Gorczyca, R. Jankowska, I. Porebska, D. Witkowska, M. Kuropatwa
4. Induction of autoantibodies and autoimmune diseases
The pristane model of lupus
W. H. Reeves, H. B. Richards, A. Mizutani, H. Yoshida, D. Nacionales, M. Satoh
Infectious origin of antiphospholipid syndrome
Y. Shoenfeld, M. Blank
Oxidative modification of autoantigens
B. T. Kurien, K. Hensley, S. Ganick, M. Bachmann, R. H. Scofield
Epitopes and complementary epitopes of autoantigens: Clinical and biologic significance
A. Tzioufas, J. G. Routsias, H. M. Moutsopoulos
Linear epitopes of two different autoantigens (La/SSB and myelin basic protein) with molecular similarity, produce different humoral responses
A. Terzoglou, J. G. Routsias, C. Sakarellos, M. Sakarellos-Daitsiotis, H. M. Moutsopoulos, A. G. Tzioufas
Induction of T cell dependent idiotypic / anti-idiotypic antibody response by complementary peptides from the immunodominant epitope 289-308 of the La/SSB autoantigen
M. G. Papamattheou, J. G. Routsias, E. E. Karagouni, C. Sakarellos,M. Sakarellos-Daitsiotis, H. M. Moutsopoulos, A. G. Tzioufas, E. N. Dotsika
Rapid onset of intra- and inter-molecular epitope spreading by immunization with 4-hydroxy-2-nonenal modified 60 kDa-Ro
B. T. Kurien, S. Ganick, D. Obeso, M. McClain, Q. Pye, R. Schneider, R. H. Broyles, J. A. James, M. Bachmann, J. B. Harley, K. Hensley, R. H. Scofield
Induction of autoantibodies in different mouse strains by the C-terminal
peptide of SmD1 83-119
G. Riemekasten, D. Langnickel, P. Enghard, A. Meine, F. Hiepe
Apoptosis, a mechanism to break tolerance?
M. P. Bachmann, J. A. Gross, Z. Pan, A. D. Farris
Apoptotic cleavage of the LEDGF/p75 autoantigen: Mechanism, impact on function, and possible role in the induction of autoantibodies
V. Ganapathy, X. Wu, T. Brown, T. Daniels, C. A. Casiano
Mice transgenic for human La are tolerant to La antigen in the form of late apoptotic cells
Z. Pan, K. Davis, M. P. Bachmann, A. D. Farris
Influence of Th1 and Th2 cytokines on the primary and secondary immune response in vitro
I. Sterzl, J. Votruba, P. Matucha, J. Sterzl
Relationship between rheumatoid factors, immune complexes and galactosylation status of IgG during humoral immune response in hyperimmunized rabbits
D. Ciric, N. Milosevic-Jovcic, V. Ilic, L. Hajdukovic-Dragojlovic
Characteristics of the anti-dsDNA autoantibody response induced by Infliximab
P. Charles, L. Aarden, R. N. Maini
Antinuclear antibody profile following infliximab treatment in rheumatoid arthritis and spondyloarthropathy.
L. De Rycke, N. van Damme, E. Kruithof, I. E. A. Hoffman, F. van den Bosch, E. M. Veys, F. de Keyser
Immune response to neo- or recall antigens is not altered by alefacept
A. Gottlieb, A. Vaishnaw, K. Gordon
Alefacept (human LFA-3/IgG1) is well tolerated and non-immunogenic: Results of two randomized, placebo-controlled phase III trials
G. Krueger, A. Vaishnaw, K. Gordon
Complexes of natural autoantibodies with histones perform role of novel autoantibodies
D. N. Abakushin, A. M. Poverenny
The reactivity of human serum IgM antibodies with Salmonella outer membrane proteins as a potential marker of Salmonella carrier
A. Gamian, D. Witkowska, M. Staniszewska, W. Gorczyca, L. Maslowski
Reactivity of antibodies against human muscle beta-enolase with bacterial outer membrane proteins
D. Witkowska, J. Pietkiewicz, B. Szostko, A. Gamian
Increased blood plasma concentrations of TGF-ß in patients with multiple sclerosis after treatment with IVIG
D. Reinhold, K. Schrecke, E. Perlov, H.-J. Heinze, M. Sailer
5. Pathogenic effects of autoantibodies
Understanding the pathogenesis of ANCA: Were are we today?
E. Csernok
Antibodies with catalytic activity
J. Bayry, S. Lacroix-Desmazes, D. Stahl, N. Misra, S. Delignat, V. Donkova, A. Pashov, M. D Kazatchkine, S. V. Kaveri
GM1-specific antibodies trigger leukocyte inflammatory functions via IgG receptors
N. M. van Sorge, W.-L. van der Pol, P. A. van Doorn, J. van Strijp, J. G. J. van de Winkel, L. H. van den Berg
Pathogenic effects of anti-retinal autoantibodies of autoimmune retinopathy
G. Ren, S. Shiraga, G. Adamus
The effects of pathogenic antibodies to type II collagen on cartilage synthesis in vitro
S. F. Amirahmadi, M-P. van Damme, M. J. Rowley
Evidence for immunity to type II collagen in the pathogenesis of rheumatoid arthritis: High frequency of antibodies to collagen fragment CB10
M. J. Rowley, A. D. Cook, A. Stockman
Binding properties of a sequence-specific pathogenic Lupus anti-ssDNA autoantibody
J. Cleary, J. Beckingham, R. Glick, G. D. Glick
Molecular dissection of the Goodpasture epitope
T. Hellmark, K. Bolton, J. Wieslander
The TNF-alpha induced upregulation of 52kD Ro/SSA autoantigen expression in human keratinocytes is mediated via TNF-alpha receptor I (TNF-RI)
B. Hostmann, V. Ruppert, M. Gerl, A. Waka, C. Johnen, F. Hiepe
6. Pathogenic autoantibodies in pregnancy
Autoantibodies associated with reproductive failure
M. Blank, Y. Sherer, Y. Shoenfeld
Pathogenesis of congenital heart block: Autoantibody insult to fibrosis
J. Buyon, R. M. Clancy
Peptide display library to identify mimotopes of autoantigens associated with neonatal lupus
R. M. Clancy, F. Di Donato, E. K. L. Chan, J. P. Buyon
7. Autoantibodies against receptor structures - Pathogenesis and therapy of anti-receptor-antibody induced diseases
The pathophysiological role of autoantibodies directed to G-protein coupled receptors and therapeutic strategies of antibody removal
G. Wallukat, E. Nissen, J. Müller, R. Brinckmann, I. Schimke, R. Kunze
Autoantibodies against the beta1-adrenoceptor increase L-type Ca2+-current in human atrial myocytes
T. Christ, D. Dobrev, E. Wettwer, D. Müller, M. Knaut, G. Wallukat, U. Ravens
Translocation of the transcription factor NF-kappa B from cytoplasm into nucleus in cultured cells induced by TNF-alpha, and autoantibodies against alpha1-adrenergic and AT1 receptor
W. Schulze, V. Homuth, E. Nissen, D. Neichel, P. S. Leung, G. Wallukat
Functional monoclonal antibodies against the human beta1-adrenergic receptor
R. Mobini, A. Staudt, G. Wallukat, A. Mijares, J. Hoebeke
Induction of beta1-adrenergic receptor-directed autoimmune cardiomyopathy in the rat
R. Jahns, V. Boivin, S. Triebel, L. Hein, G. Ertl, C. E. Angermann, M. J. Lohse
The occurrence of autoantibodies against G-protein coupled receptors is associated with oxidative stress
I. Schimke
Specific removal of autoantibodies against beta1-adrenergic receptor from patients with dilated cardiomyopathy: Results from a pilot study
J. Müller
Agonistic antibodies targeting Angiotensin II type 1 receptor cause acute vascular rejection in the absence of immunological risk
D. Dragun, G. Wallukat, R. Dechend, J. H. Bräsen, D. N. Müller, H.-H. Neumayer, K. Budde, F. C. Luft
8. Autoantibodies in skin diseases
Pathogenic role of anti-Ro/SS-A autoantibodies in cutaneous manifestations of Lupus erythematosus
V. Ruppert, B. Hostmann, F. Hiepe
Anti-fibroblast autoantibodies in systemic sclerosis
P. L. Meroni, N. Ronda, E. Raschi, C. Testoni, M. O. Borghi, R. Gatti, J. M. Dayer, G. Orlandi, C. Chizzolini
Identity of the RNase MRP and RNase P associated Th/To-autoantigen
H. van Eenennaam, J. H. P. Vogelzangs, D. Lugtenberg, F. H. J. van den Hoogen, W. J. van Venrooij, G. J. M. Pruijn
Autoantibody populations directed against different transglutaminase isoenzymes in dermatitis herpetiformis and coeliac disease
M. Sßrdy, S. Kßrpati, B. Merkl, M. Paulsson, N. Smyth
Molecular pathomechanisms of autoimmune subepidermal bullous skin diseases
A. Kromminga, D. Zillikens
A Highly Sensitive and Simple Assay for the Detection of Circulating Autoantibodies against Full-Length Bullous Pemphigoid Antigen 180
E. Schmidt, A. Kromminga, S. Mimietz, U. Leinfelder, E.-B. Bröcker, D. Zillikens, U. Zimmermann
Anti-stratum corneum antibodies in active psoriasis
M. Cojocaru, S. Popescu, A. Cimpean, D. Iordachescu, M. Costache
9. Autoantibodies against citrullinated antigens
Anti-CCP antibodies in (early) rheumatoid arthritis
E. R. Vossenaar, W. J. van Venrooij, G. J. M. Pruijn
"Citrullinated" antigens as targets of rheumatoid arthritis specific autoimmune responses
S. Chapuy-Regaud, M. Sebbag, L. Nogueira, C. Vincent, G. Serre
Anti-citrullinated peptides autoantibodies or anti-filaggrin autoantibodies: What is the best for diagnosis of RA?
C. Ferraro-Peyret, J. Tebib, S. Veber, N. Fabien
Detection of anti-CCP and diagnosis of rheumatoid arthritis
R. W. Burlingame, R. Morris, A. Metzger, C. von Muhlen, M. H. Wener, C. L. Peebles, A. L. Piette
Comparison of anti-CCP (cyclic citrullinated peptide) assays in rheumatoid arthritis
A. Mustila, A. M. Haapala
Comparison of several laboratory tests used in diagnostics of rheumatic diseases
I. Lochman, V. Novßk, A. Kloudovß, A. Lochmanovß
Antibodies to cyclic citrullinated peptide in RA: A sensitive and specific diagnostic marker
P. J. Charles, R. N. Maini
The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
V. P. K. Nell, K. P. Machold, W. Hueber, G. Eberl, H. Hiesberger, E. Hoefler, J. S. Smolen, G. Steiner
Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
I. Hromadnikova, K. Stechova, P. Vavrincova, D. Hridelova, H. Nekvasilova, H. Reitzova, J. Vavrinec
Juvenile idiopathic arthritis and anti-keratin/anti-CCP antibodies
K. Conrad, J. Oppermann, D. Möbius, M. Borte, G. Heubner
10. Autoantibodies in thrombotic diseases and atherosclerosis
Anti-prothrombin antibodies: Pathogenesis and specificity
T. Koike, T. Horita, K. Ichikawa, O. Amengual, T. Atsumi
Antibodies against ß2 glycoprotein 1 and cardiolipin in rheumatoid arthritis patients with cardiovascular diseases
A. Durazinska, M. Szmyrka, B. Jazwiec, J. Szechinski
Relationship between autoantibodies against oxidized LDL, lipid peroxidation products and cytokine profile in diabetic type 2 patients
H.Donica, M. Koziol-Montewka, E. Staroslawska
Antineutrophil cytoplasmic antibodies in patients with Buerger's disease
I. M. Manolova, D. P. Petkov, M. Gulubova
Anti-cholesterol antibodies in atherosclerosis
A. Horvath, G. Füst, P. Antal-Szalmßs, I. Csipö, S. Sipka, I. Karßdi
Anti beta-2 glycoprotein 1 antibodies and 17 beta-estradiol serum levels in female rheumatoid arthritis patients
R. Sokolik, A. Durazinska, M. Szmyrka, J.Szechinski
Evaluation of a renewed cardiolipin antibody assay - requirements of GMP confirm production
W. Papisch, T. Frey, B. Berg
11. Autoantibodies in liver and gastrointestinal diseases
The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease
T. Freitag, G. Melino, H. Schulze-Koops, G. Niedobitek, E. G. Hahn, D. Schuppan
Biological functions of coeliac disease autoantibodies
T. Halttunen, R. Marzari, D. Sblattero, M. Mäki
Anti-tissue transglutaminase antibodies: Prevalence and clinical significance in connective tissue diseases and autoimmune gastro-intestinal diseases
N. Bizzaro, D. Villalta, E. Tonutti , A. Doria, M. Tampoia, D. Bassetti, R. Tozzoli
Assay of coeliac disease autoantibodies applying an ELISA with human tissue transglutaminase
A. A. Osman, T. Richter, M. Stern, K. Conrad, J. Henker, C. Brandsch, K.-P. Zimmer, T. Mothes
Reactivity of mouse gliadin antibodies with deamidated gliadin
F. Kahlenberg, I. Lachmann, S. Tschiedel, J. Schneider-Mergener, A. A. Osman, U. Sack, T. Mothes
Prevalence of pancreatic autoantibodies in patients with inflammatory bowel disease (IBD), their first-degree relatives and spouses
S. Joossens, L. Godefridis, G. Claessens, S. Vermeire, M. Pierik, N. Esters, R. Aerts, X. Bossuyt, P. Rutgeerts
ANCA and inflammatory bowel disease: Antigenic specificity
E. Mainardi, L. Cresci, M. T. Romagnoli, A. Vagni, P. Galli, A. Montanelli
ANCA target antigen(s) in patients with autoimmune hepatitis
A. Kozmar, R. Ostojic, Z. Krznaric, B. Vucelic, B. Malenica
Prevalence of anti-UDP-glucuronosyltransferase autoantibodies in patients with autoimmune hepatitis.
A. Desbos, J. Magdalou, E. Benoit, F. Lapicque, J. C. Monier, S. Veber, N. Fabien
Detection of antiphospholipid-antibodies in patients with primary biliary cirrhosis and autoimmune hepatitis
P. von Landenberg, R. Schlichting, J. Schölmerich, G. Lock
The frequency and pattern of autoantibodies and immunoglobulin levels in chronic hepatitis
A. Pituch-Noworolska, A. Macura-Biegun
Prevalence of various autoantibodies in patients infected with hepatitis C virus
V. Tabor, M. Fucek, I. Hrstic, Z. Krznaric, B. Vucelic, B. Malenica
Laboratory findings in autoimmune liver diseases patients in the Sverdlovsk region, Russia
V. V. Bazarny, E. N. Bessonova, D. A. Mazein, O. M. Lesnyak
12. Autoantibodies in neurological and endocrine diseases
Autoimmune disorders of the neuromuscular junction
B. Lang, A. Vincent
Diversity of neurological disorders with anti-GAD antibodies
J. Honnorat
Paraneoplastic neuropathies - Clinical and immunological features
F. Blaes, M. Klotz, M. Tschernatsch, J. Kraus, I. Krasenbrink, M. Kaps
Clinical outcome of paraneoplastic cerebellar degeneration associated with antineuronal antibodies in 48 patients
S. Shams-Ili, J. Grefkens, B. de Leeuw, H. Hooijkaas, P. Sillevis Smitt
Autoantibodies in children and adults with paraneoplastic Opsoclonus-myoclonus syndrome
V. Fühlhuber, I. Krasenbrink, I. Juhasz-Böss, M. Klotz, M. Kaps, F. Blaes
EUROLINE-WB allows reliable differentiation of autoantibodies against neuralantigens in patients with paraneoplastic neurological syndrome
T. Scheper, M. Klotz, W. Meyer, W. Schlumberger, W. Stöcker
Autoantibodies to gangliosides in patients with multiple sclerosis and normal healthy controls
C. Wehrend, U. Sack, F. Emmrich, M. Kamprad
Analytical and clinical evaluation of second generation assays for thyrotropin receptor antibodies.
D. Villalta, R. Tozzoli, E. Orunesu, P. Montagna, G. Pesce, N. Bizzaro, M. Bagnasco
Cytofluorimetric evaluation of antigen regions of thyroid peroxidase in patients with Graves' disease and non-toxic nodular goiter
A. Bossowski, A. Stasiak-Barmuta, B. Czarnocka, M. Urban, J. Dadan
Reactivity of anti-liver-kidney microsome type 1 (LKM-1) antibodies in the sera of patients with type 1 diabetes mellitus
O. Neacsu, M. Cojocaru, I. Cojocaru, D. Cheta
Study of anti-actin and anti-myosin antibodies in myasthenia gravis
I. Cojocaru, M. Cojocaru, R. Tanasescu, C. Musuroi
Autoantibodies in Hashimoto's encephalitis
J. Abu-Isa, M. Bodemer, S. Poser, A. Schlüter, I. Zerr
HLA association with autoimmune endocrinopathies
P. Hrdß, F. Korioth, P. Matucha, I. Sterzl, A. Kromminga
Prevalence of antitransglutaminase antibodies in a pediatric population with type 1 diabetes.
F. Bienvenu, N. Peretti, A. Lachaux, M. Nicolino, G. Tanzilli, C. Bouvet, R. Bouvier, S. Veber, J. Bienvenu, N. Fabien
Multiple and high-titer single autoantibodies in schoolchildren reflecting the genetic predisposition for type 1 diabetes
M. Schlosser, R. Wassmuth, M. Strebelow, I. Rjasanowski, B. Ziegler, M. Ziegler
Autoantibody profile in acute inner ear diseases
M. Kamprad, K. Donaubauer, K. Conrad, B. Kniep, U. Fickweiler, H. Müller, U. Sack
13. Autoantibodies and epidemiology
The epidemiology of autoimmune diseases: Contribution of previous studies and opportunities for future research
G. Cooper
The role of exogenous factors in the induction of autoantibodies
K. Geisenhoffer, D. Germolec
Iodine prophylaxis and risk of arising autoimmune thyroid diseases in children
V. Aranovich, M. Svinarev
Autoantibodies in risk groups for autoimmune diseases
K. Conrad, J. Mehlhorn
14. Methodical aspects and diagnostic strategies
ANA
Clinical and laboratory evalution of an ELISA, indirect immunofluorescence and a new automated fluorescence immunoassay for detection on antinuclear antibodies
A.-M. Haapala, A. Mustila, M. Pertovaara
Comparison of screening by IIF (HEp 2) and an ANA ELISA vs a new automated ANA/ENA screening (EliA) in patients from routine
M. l. Casas, F. Cava, F. J. Fernandez, S. Valor, J. M. Gonzalez-Buitrago, C. Gonzalez, B. Garcia, J. A. Navajo, W. Papisch
Comparison of screening by IIF (HEp 2) vs a new automated ANA/ENA screening (EliA) in defined patients
C. Gonzalez, J. M. Buitrago, M. Casas, F. Cava, B. Garcia, J. A. Navajo, W. Papisch, S. Valor
Pattern of humoral autoimmunity in patients with breast cancer
M. Volkmann, Y. Hajjar, J. Huober, D. Gaugel, J. Ludwig, S. Hänsel, G. Bastert, H. Zentgraf, D. Wallwiener, W. Fiehn
Nucleosome and dsDNA antibodies
A comparative study of the diagnostic efficiency of anti-dsDNA antibody tests in systemic lupus erythematosus
B. Schlüter, L. Kaucikaite, H. Schotte, P. Willeke, H. Becker, A. Dyong, J. Haier, R. Gellner, G. Bonsmann, M. Gaubitz
Clinical evaluation of a new dsDNA-RIA
R. Wöhrle, P. von Landenberg, M. Oppermann, K. Helmke, T. Witte
Detection of dsDNA antibodies in SLE: Efficiency of the automated EliA-immunoassay in comparison with non-automated systems
D. Kuhn, S. Kadler, E. Boehme, M. Linnemann
Performance of a new automated fluorescence immunoassay (EliATM dsDNA) for the follow-up of anti-ds DNA antibodies in SLE patients
A. Lakaf, C. Sapin, V. Moal, J. R. Harlé, M. Sanmarco
Detection of dsDNA antibodies in SLE: A case report based evaluation of discrepant results between the automated EliA immunoassay and an established non-automated assay
D. Kuhn, S. Kadler, E. Boehme, M. Linnemann
Comparison of two different methods for detection of dsDNA antibodies related to SLE patients at different disease status
M. Rodriguez-Mahou, F. J. López-Longo, J. L. Ruiz-Tiscar, E. F. dez-Cruz
Autoantibodies against nucleosomes are pathognomonic for SLE - A 2nd generation ELISA shows no reactivity with sera from scleroderma patients
W. Schlumberger, C. Daehnrich, W. Suer, S. Frahm, W. Stoecker
The benefit of anti-deoxyribonucleoprotein (anti-DNP) antibodies determination in the laboratory of clinical immunology
I. Lochman, L. Cebecauer, V. Novßk, H. Tomßckovß, A. Kloudovß, A. Lochmanovß
ENA antibodies
Evaluation of the detection of anti-dsDNA and -ENA antibodies by a new automated fluorescence immunoassay
M. López-Hoyos, H. López-Escribano, M. Peña, M. J. Bartolomé
Evaluation of EliATM screening and detection of antibodies directed against extractable nuclear antigens
E. Oris, C. Bunn, G. Godefridis, N. Kolbus, W. Papisch, X. Bossuyt
A new fluorescence immunoassay (EliA(tm) Sm) for the detection of anti-Sm antibodies
M. Mahler, R. C. Williams
A new LINE immunoassay for the detection of myositis-specific autoantibodies
C. Hentschel, J. Schulte-Pelkum, W. Schößler, F. Hiepe, R. Mierau, K. Conrad
Antibodies against SS-A can only be precisely detected using the native antigen: Results of a study using the EUROLINE-WB
W. Meyer, T. Scheper, K. Wilhelm, M. Jarzabek-Chorzelska, Z. Kolacinska-Strasz, W. Schlumberger, W. Stoecker
ANCA and GBM antibodies
Increased specificity for systemic vasculitis with capture ELISA for MPO-ANCA?
M. Carlsson, J. Wieslander, M. Segelmark
Evaluation of a new sensitive ELISA for the detection of PR3 Antibodies
M. Mahler, P. Höpfl, E. Mummert
Antineutrophil cytoplasmic antibodies in connective tissue diseases
G. Kirdaite, J. Dadonien, E. Redaitiene
Serum anti-glomerular basement membrane antibodies in patients with renopulmonary syndrome
D. Iordanescu, M. Cojocaru, I. Cojocaru, O. Neacsu
1. The impact of genomics/ribonomics/proteomics on autoantigen and autoantibody research
Using messenger RNP autoantibodies to reveal networks of posttranscriptional operons
J. Keene, S. A. Tenenbaum
Modern techniques in mass spectrometry based proteomics
M. Mann, J. Andersen, Y. Ishihama, J. Rappsilber, S. Ong, L. Foster, B. Blagoev, I. Kratchmarova, E. Lasonder
The use of phage display to identify a conformational autoepitope in primary biliary cirrhosis
M. Scealy, I.R. Mackay, M.J. Rowley
Anti-citrulline antibodies and citrullinating enzymes in RA
E. R. Vossenaar, T. Radstake, A. van der Heijden, P. Barrera, G. Pruijn, W. J. van Venrooij
A study of overlapping epitopes recognised by antibodies to GAD65 using phage display
K. H. O'Connor, M. Scealy, M. J. Rowley
Epitope-fine mapping of the major C-terminal epitope of the ribosomal P- proteins
M. Mahler, K. Kessenbrock, J. Raats, M. Blüthner
2. New diagnostic techniques in autoantigen/autoantibody analyses
New technologies in the detection of autoantibodies: The present and future
M. Fritzler
Systematic analyses of microbial antigens and infection induced autoimmunity
P. Krebs, B. Ludewig, B. Metters, O. Türeci, R. M. Zinkernagel, H. Hengartner, U. Sahin
Line-assay with recombinant antigens for diagnosis of systemic autoimmune rheumatic diseases
T. Kattenfeld, A. Kromminga, M. Motz
Three multiplexed tests for extractable nuclear antigens using the Luminex 100
R. W. Burlingame, A. L. Piette, C. von Mühlen, K. M. Pollard, W. L. Binder
The BIOONE(r) system: the new dosage of autoantibodies
L. Voorn, P. Backelandt, A. Duyckaerts, L. Zecchinon, T. Swiatkowski, A. Bosseloir
Automatized classification of HEp-2-cell based indirect immunofluorescence patterns by a novel computerized system
U. Sack, S. Knöchner, P. Perner, U. Pigla, M. Kamprad
Simple and sensitive detection of serum autoantibodies to full-length bullous pemphigoid antigen 180
E. Schmidt, A. Kromminga, D. Zillikens, U. Zimmermann
Rapid flow cytometric differentiation of anti-platelet antibodies with microspheres
M. Woetzel, S. Schroeder, U. Sack, F. Emmrich
3. Novel autoantibodies of diagnostic and / or pathogenic relevance
Novel cytoplasmic mRNP compartment recognized by human autoantibodies
E. K. L. Chan
Autoimmune response to glyceraldehyde-3-phosphatase dehydrogenase (GAPDH) is strongly associated with its cellular function in lupus patients
Y. Takasaki, K. Kaneda, H. Yamada, M. Nawata, K. Ikeda, M. Matsushita, R. Matsudairav, K. Takeuchi, N. Shindo, K. Murayama, H. Hashimoto
Translational regulators as autoantigens in systemic autoimmune diseases
G. Steiner, K. Skriner, G. Fabini, E. Jimenez-Boj, N. Kedersha, C. Zimmermann, M. Tohidast-Akrad, G. Schett, R. Fritsch, E. Höfler, P. Anderson, J. Smolen
Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations
H. van Eenennaam, J. H. P. Vogelzangs, L. Bisschops, L. C. J. te Boome, H. P. Seelig, M. Renz, D.-J. de Rooij, R. Brouwer, H. P. Pluk, W. J. van Venrooij, F. H. J. van den Hoogen, G. J. M. Pruijn
Prevalence of Antibodies against Alpha-Fodrin in Sjögren´s syndrome: Comparison of two Sets of Classification Criteria
T. Witte, T. Matthias, M. Oppermann, K. Helmke, H. H. Peter, R. E. Schmidt, M. Tishler
New antibody pattern in liver transplant patients with genetic donor-recipient incompatibility for GSTT1 - Correlation with de novo-immune mediated hepatitis and monoclonal gammopathy
I. Wichmann, I. Aguilera, J. M. Sousa, A. Bernardos, E. Franco, J. R. García-Lozano, A. Núñez-Roldßn
Identification and molecular characterization of two autoantibody systems associated with the indirect immunofluorescence cytoplasm discrete speckled (IIF-CDS) pattern
C. C. F. C. Laurino, N. P. Silva, A. H. Straus, H. K. Takahashi, M. Benchimol, I. C. Almeida, R. Mortara, R. Tedesco, L. E. C. Andrade
NY-ESO1 autoantibody - a novel candidate for early diagnosis of lung cancer
K. Conrad, P. Krause, O. Türeci, W. Heine, U. Luxemburger, J. Mehlhorn, U. Sahin
Antibodies recognizing different retinal antigens are present in sera of patients with lung diseases
W. A. Gorczyca, R. Jankowska, I. Porebska, D. Witkowska, M. Kuropatwa
4. Induction of autoantibodies and autoimmune diseases
The pristane model of lupus
W. H. Reeves, H. B. Richards, A. Mizutani, H. Yoshida, D. Nacionales, M. Satoh
Infectious origin of antiphospholipid syndrome
Y. Shoenfeld, M. Blank
Oxidative modification of autoantigens
B. T. Kurien, K. Hensley, S. Ganick, M. Bachmann, R. H. Scofield
Epitopes and complementary epitopes of autoantigens: Clinical and biologic significance
A. Tzioufas, J. G. Routsias, H. M. Moutsopoulos
Linear epitopes of two different autoantigens (La/SSB and myelin basic protein) with molecular similarity, produce different humoral responses
A. Terzoglou, J. G. Routsias, C. Sakarellos, M. Sakarellos-Daitsiotis, H. M. Moutsopoulos, A. G. Tzioufas
Induction of T cell dependent idiotypic / anti-idiotypic antibody response by complementary peptides from the immunodominant epitope 289-308 of the La/SSB autoantigen
M. G. Papamattheou, J. G. Routsias, E. E. Karagouni, C. Sakarellos,M. Sakarellos-Daitsiotis, H. M. Moutsopoulos, A. G. Tzioufas, E. N. Dotsika
Rapid onset of intra- and inter-molecular epitope spreading by immunization with 4-hydroxy-2-nonenal modified 60 kDa-Ro
B. T. Kurien, S. Ganick, D. Obeso, M. McClain, Q. Pye, R. Schneider, R. H. Broyles, J. A. James, M. Bachmann, J. B. Harley, K. Hensley, R. H. Scofield
Induction of autoantibodies in different mouse strains by the C-terminal
peptide of SmD1 83-119
G. Riemekasten, D. Langnickel, P. Enghard, A. Meine, F. Hiepe
Apoptosis, a mechanism to break tolerance?
M. P. Bachmann, J. A. Gross, Z. Pan, A. D. Farris
Apoptotic cleavage of the LEDGF/p75 autoantigen: Mechanism, impact on function, and possible role in the induction of autoantibodies
V. Ganapathy, X. Wu, T. Brown, T. Daniels, C. A. Casiano
Mice transgenic for human La are tolerant to La antigen in the form of late apoptotic cells
Z. Pan, K. Davis, M. P. Bachmann, A. D. Farris
Influence of Th1 and Th2 cytokines on the primary and secondary immune response in vitro
I. Sterzl, J. Votruba, P. Matucha, J. Sterzl
Relationship between rheumatoid factors, immune complexes and galactosylation status of IgG during humoral immune response in hyperimmunized rabbits
D. Ciric, N. Milosevic-Jovcic, V. Ilic, L. Hajdukovic-Dragojlovic
Characteristics of the anti-dsDNA autoantibody response induced by Infliximab
P. Charles, L. Aarden, R. N. Maini
Antinuclear antibody profile following infliximab treatment in rheumatoid arthritis and spondyloarthropathy.
L. De Rycke, N. van Damme, E. Kruithof, I. E. A. Hoffman, F. van den Bosch, E. M. Veys, F. de Keyser
Immune response to neo- or recall antigens is not altered by alefacept
A. Gottlieb, A. Vaishnaw, K. Gordon
Alefacept (human LFA-3/IgG1) is well tolerated and non-immunogenic: Results of two randomized, placebo-controlled phase III trials
G. Krueger, A. Vaishnaw, K. Gordon
Complexes of natural autoantibodies with histones perform role of novel autoantibodies
D. N. Abakushin, A. M. Poverenny
The reactivity of human serum IgM antibodies with Salmonella outer membrane proteins as a potential marker of Salmonella carrier
A. Gamian, D. Witkowska, M. Staniszewska, W. Gorczyca, L. Maslowski
Reactivity of antibodies against human muscle beta-enolase with bacterial outer membrane proteins
D. Witkowska, J. Pietkiewicz, B. Szostko, A. Gamian
Increased blood plasma concentrations of TGF-ß in patients with multiple sclerosis after treatment with IVIG
D. Reinhold, K. Schrecke, E. Perlov, H.-J. Heinze, M. Sailer
5. Pathogenic effects of autoantibodies
Understanding the pathogenesis of ANCA: Were are we today?
E. Csernok
Antibodies with catalytic activity
J. Bayry, S. Lacroix-Desmazes, D. Stahl, N. Misra, S. Delignat, V. Donkova, A. Pashov, M. D Kazatchkine, S. V. Kaveri
GM1-specific antibodies trigger leukocyte inflammatory functions via IgG receptors
N. M. van Sorge, W.-L. van der Pol, P. A. van Doorn, J. van Strijp, J. G. J. van de Winkel, L. H. van den Berg
Pathogenic effects of anti-retinal autoantibodies of autoimmune retinopathy
G. Ren, S. Shiraga, G. Adamus
The effects of pathogenic antibodies to type II collagen on cartilage synthesis in vitro
S. F. Amirahmadi, M-P. van Damme, M. J. Rowley
Evidence for immunity to type II collagen in the pathogenesis of rheumatoid arthritis: High frequency of antibodies to collagen fragment CB10
M. J. Rowley, A. D. Cook, A. Stockman
Binding properties of a sequence-specific pathogenic Lupus anti-ssDNA autoantibody
J. Cleary, J. Beckingham, R. Glick, G. D. Glick
Molecular dissection of the Goodpasture epitope
T. Hellmark, K. Bolton, J. Wieslander
The TNF-alpha induced upregulation of 52kD Ro/SSA autoantigen expression in human keratinocytes is mediated via TNF-alpha receptor I (TNF-RI)
B. Hostmann, V. Ruppert, M. Gerl, A. Waka, C. Johnen, F. Hiepe
6. Pathogenic autoantibodies in pregnancy
Autoantibodies associated with reproductive failure
M. Blank, Y. Sherer, Y. Shoenfeld
Pathogenesis of congenital heart block: Autoantibody insult to fibrosis
J. Buyon, R. M. Clancy
Peptide display library to identify mimotopes of autoantigens associated with neonatal lupus
R. M. Clancy, F. Di Donato, E. K. L. Chan, J. P. Buyon
7. Autoantibodies against receptor structures - Pathogenesis and therapy of anti-receptor-antibody induced diseases
The pathophysiological role of autoantibodies directed to G-protein coupled receptors and therapeutic strategies of antibody removal
G. Wallukat, E. Nissen, J. Müller, R. Brinckmann, I. Schimke, R. Kunze
Autoantibodies against the beta1-adrenoceptor increase L-type Ca2+-current in human atrial myocytes
T. Christ, D. Dobrev, E. Wettwer, D. Müller, M. Knaut, G. Wallukat, U. Ravens
Translocation of the transcription factor NF-kappa B from cytoplasm into nucleus in cultured cells induced by TNF-alpha, and autoantibodies against alpha1-adrenergic and AT1 receptor
W. Schulze, V. Homuth, E. Nissen, D. Neichel, P. S. Leung, G. Wallukat
Functional monoclonal antibodies against the human beta1-adrenergic receptor
R. Mobini, A. Staudt, G. Wallukat, A. Mijares, J. Hoebeke
Induction of beta1-adrenergic receptor-directed autoimmune cardiomyopathy in the rat
R. Jahns, V. Boivin, S. Triebel, L. Hein, G. Ertl, C. E. Angermann, M. J. Lohse
The occurrence of autoantibodies against G-protein coupled receptors is associated with oxidative stress
I. Schimke
Specific removal of autoantibodies against beta1-adrenergic receptor from patients with dilated cardiomyopathy: Results from a pilot study
J. Müller
Agonistic antibodies targeting Angiotensin II type 1 receptor cause acute vascular rejection in the absence of immunological risk
D. Dragun, G. Wallukat, R. Dechend, J. H. Bräsen, D. N. Müller, H.-H. Neumayer, K. Budde, F. C. Luft
8. Autoantibodies in skin diseases
Pathogenic role of anti-Ro/SS-A autoantibodies in cutaneous manifestations of Lupus erythematosus
V. Ruppert, B. Hostmann, F. Hiepe
Anti-fibroblast autoantibodies in systemic sclerosis
P. L. Meroni, N. Ronda, E. Raschi, C. Testoni, M. O. Borghi, R. Gatti, J. M. Dayer, G. Orlandi, C. Chizzolini
Identity of the RNase MRP and RNase P associated Th/To-autoantigen
H. van Eenennaam, J. H. P. Vogelzangs, D. Lugtenberg, F. H. J. van den Hoogen, W. J. van Venrooij, G. J. M. Pruijn
Autoantibody populations directed against different transglutaminase isoenzymes in dermatitis herpetiformis and coeliac disease
M. Sßrdy, S. Kßrpati, B. Merkl, M. Paulsson, N. Smyth
Molecular pathomechanisms of autoimmune subepidermal bullous skin diseases
A. Kromminga, D. Zillikens
A Highly Sensitive and Simple Assay for the Detection of Circulating Autoantibodies against Full-Length Bullous Pemphigoid Antigen 180
E. Schmidt, A. Kromminga, S. Mimietz, U. Leinfelder, E.-B. Bröcker, D. Zillikens, U. Zimmermann
Anti-stratum corneum antibodies in active psoriasis
M. Cojocaru, S. Popescu, A. Cimpean, D. Iordachescu, M. Costache
9. Autoantibodies against citrullinated antigens
Anti-CCP antibodies in (early) rheumatoid arthritis
E. R. Vossenaar, W. J. van Venrooij, G. J. M. Pruijn
"Citrullinated" antigens as targets of rheumatoid arthritis specific autoimmune responses
S. Chapuy-Regaud, M. Sebbag, L. Nogueira, C. Vincent, G. Serre
Anti-citrullinated peptides autoantibodies or anti-filaggrin autoantibodies: What is the best for diagnosis of RA?
C. Ferraro-Peyret, J. Tebib, S. Veber, N. Fabien
Detection of anti-CCP and diagnosis of rheumatoid arthritis
R. W. Burlingame, R. Morris, A. Metzger, C. von Muhlen, M. H. Wener, C. L. Peebles, A. L. Piette
Comparison of anti-CCP (cyclic citrullinated peptide) assays in rheumatoid arthritis
A. Mustila, A. M. Haapala
Comparison of several laboratory tests used in diagnostics of rheumatic diseases
I. Lochman, V. Novßk, A. Kloudovß, A. Lochmanovß
Antibodies to cyclic citrullinated peptide in RA: A sensitive and specific diagnostic marker
P. J. Charles, R. N. Maini
The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
V. P. K. Nell, K. P. Machold, W. Hueber, G. Eberl, H. Hiesberger, E. Hoefler, J. S. Smolen, G. Steiner
Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
I. Hromadnikova, K. Stechova, P. Vavrincova, D. Hridelova, H. Nekvasilova, H. Reitzova, J. Vavrinec
Juvenile idiopathic arthritis and anti-keratin/anti-CCP antibodies
K. Conrad, J. Oppermann, D. Möbius, M. Borte, G. Heubner
10. Autoantibodies in thrombotic diseases and atherosclerosis
Anti-prothrombin antibodies: Pathogenesis and specificity
T. Koike, T. Horita, K. Ichikawa, O. Amengual, T. Atsumi
Antibodies against ß2 glycoprotein 1 and cardiolipin in rheumatoid arthritis patients with cardiovascular diseases
A. Durazinska, M. Szmyrka, B. Jazwiec, J. Szechinski
Relationship between autoantibodies against oxidized LDL, lipid peroxidation products and cytokine profile in diabetic type 2 patients
H.Donica, M. Koziol-Montewka, E. Staroslawska
Antineutrophil cytoplasmic antibodies in patients with Buerger's disease
I. M. Manolova, D. P. Petkov, M. Gulubova
Anti-cholesterol antibodies in atherosclerosis
A. Horvath, G. Füst, P. Antal-Szalmßs, I. Csipö, S. Sipka, I. Karßdi
Anti beta-2 glycoprotein 1 antibodies and 17 beta-estradiol serum levels in female rheumatoid arthritis patients
R. Sokolik, A. Durazinska, M. Szmyrka, J.Szechinski
Evaluation of a renewed cardiolipin antibody assay - requirements of GMP confirm production
W. Papisch, T. Frey, B. Berg
11. Autoantibodies in liver and gastrointestinal diseases
The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease
T. Freitag, G. Melino, H. Schulze-Koops, G. Niedobitek, E. G. Hahn, D. Schuppan
Biological functions of coeliac disease autoantibodies
T. Halttunen, R. Marzari, D. Sblattero, M. Mäki
Anti-tissue transglutaminase antibodies: Prevalence and clinical significance in connective tissue diseases and autoimmune gastro-intestinal diseases
N. Bizzaro, D. Villalta, E. Tonutti , A. Doria, M. Tampoia, D. Bassetti, R. Tozzoli
Assay of coeliac disease autoantibodies applying an ELISA with human tissue transglutaminase
A. A. Osman, T. Richter, M. Stern, K. Conrad, J. Henker, C. Brandsch, K.-P. Zimmer, T. Mothes
Reactivity of mouse gliadin antibodies with deamidated gliadin
F. Kahlenberg, I. Lachmann, S. Tschiedel, J. Schneider-Mergener, A. A. Osman, U. Sack, T. Mothes
Prevalence of pancreatic autoantibodies in patients with inflammatory bowel disease (IBD), their first-degree relatives and spouses
S. Joossens, L. Godefridis, G. Claessens, S. Vermeire, M. Pierik, N. Esters, R. Aerts, X. Bossuyt, P. Rutgeerts
ANCA and inflammatory bowel disease: Antigenic specificity
E. Mainardi, L. Cresci, M. T. Romagnoli, A. Vagni, P. Galli, A. Montanelli
ANCA target antigen(s) in patients with autoimmune hepatitis
A. Kozmar, R. Ostojic, Z. Krznaric, B. Vucelic, B. Malenica
Prevalence of anti-UDP-glucuronosyltransferase autoantibodies in patients with autoimmune hepatitis.
A. Desbos, J. Magdalou, E. Benoit, F. Lapicque, J. C. Monier, S. Veber, N. Fabien
Detection of antiphospholipid-antibodies in patients with primary biliary cirrhosis and autoimmune hepatitis
P. von Landenberg, R. Schlichting, J. Schölmerich, G. Lock
The frequency and pattern of autoantibodies and immunoglobulin levels in chronic hepatitis
A. Pituch-Noworolska, A. Macura-Biegun
Prevalence of various autoantibodies in patients infected with hepatitis C virus
V. Tabor, M. Fucek, I. Hrstic, Z. Krznaric, B. Vucelic, B. Malenica
Laboratory findings in autoimmune liver diseases patients in the Sverdlovsk region, Russia
V. V. Bazarny, E. N. Bessonova, D. A. Mazein, O. M. Lesnyak
12. Autoantibodies in neurological and endocrine diseases
Autoimmune disorders of the neuromuscular junction
B. Lang, A. Vincent
Diversity of neurological disorders with anti-GAD antibodies
J. Honnorat
Paraneoplastic neuropathies - Clinical and immunological features
F. Blaes, M. Klotz, M. Tschernatsch, J. Kraus, I. Krasenbrink, M. Kaps
Clinical outcome of paraneoplastic cerebellar degeneration associated with antineuronal antibodies in 48 patients
S. Shams-Ili, J. Grefkens, B. de Leeuw, H. Hooijkaas, P. Sillevis Smitt
Autoantibodies in children and adults with paraneoplastic Opsoclonus-myoclonus syndrome
V. Fühlhuber, I. Krasenbrink, I. Juhasz-Böss, M. Klotz, M. Kaps, F. Blaes
EUROLINE-WB allows reliable differentiation of autoantibodies against neuralantigens in patients with paraneoplastic neurological syndrome
T. Scheper, M. Klotz, W. Meyer, W. Schlumberger, W. Stöcker
Autoantibodies to gangliosides in patients with multiple sclerosis and normal healthy controls
C. Wehrend, U. Sack, F. Emmrich, M. Kamprad
Analytical and clinical evaluation of second generation assays for thyrotropin receptor antibodies.
D. Villalta, R. Tozzoli, E. Orunesu, P. Montagna, G. Pesce, N. Bizzaro, M. Bagnasco
Cytofluorimetric evaluation of antigen regions of thyroid peroxidase in patients with Graves' disease and non-toxic nodular goiter
A. Bossowski, A. Stasiak-Barmuta, B. Czarnocka, M. Urban, J. Dadan
Reactivity of anti-liver-kidney microsome type 1 (LKM-1) antibodies in the sera of patients with type 1 diabetes mellitus
O. Neacsu, M. Cojocaru, I. Cojocaru, D. Cheta
Study of anti-actin and anti-myosin antibodies in myasthenia gravis
I. Cojocaru, M. Cojocaru, R. Tanasescu, C. Musuroi
Autoantibodies in Hashimoto's encephalitis
J. Abu-Isa, M. Bodemer, S. Poser, A. Schlüter, I. Zerr
HLA association with autoimmune endocrinopathies
P. Hrdß, F. Korioth, P. Matucha, I. Sterzl, A. Kromminga
Prevalence of antitransglutaminase antibodies in a pediatric population with type 1 diabetes.
F. Bienvenu, N. Peretti, A. Lachaux, M. Nicolino, G. Tanzilli, C. Bouvet, R. Bouvier, S. Veber, J. Bienvenu, N. Fabien
Multiple and high-titer single autoantibodies in schoolchildren reflecting the genetic predisposition for type 1 diabetes
M. Schlosser, R. Wassmuth, M. Strebelow, I. Rjasanowski, B. Ziegler, M. Ziegler
Autoantibody profile in acute inner ear diseases
M. Kamprad, K. Donaubauer, K. Conrad, B. Kniep, U. Fickweiler, H. Müller, U. Sack
13. Autoantibodies and epidemiology
The epidemiology of autoimmune diseases: Contribution of previous studies and opportunities for future research
G. Cooper
The role of exogenous factors in the induction of autoantibodies
K. Geisenhoffer, D. Germolec
Iodine prophylaxis and risk of arising autoimmune thyroid diseases in children
V. Aranovich, M. Svinarev
Autoantibodies in risk groups for autoimmune diseases
K. Conrad, J. Mehlhorn
14. Methodical aspects and diagnostic strategies
ANA
Clinical and laboratory evalution of an ELISA, indirect immunofluorescence and a new automated fluorescence immunoassay for detection on antinuclear antibodies
A.-M. Haapala, A. Mustila, M. Pertovaara
Comparison of screening by IIF (HEp 2) and an ANA ELISA vs a new automated ANA/ENA screening (EliA) in patients from routine
M. l. Casas, F. Cava, F. J. Fernandez, S. Valor, J. M. Gonzalez-Buitrago, C. Gonzalez, B. Garcia, J. A. Navajo, W. Papisch
Comparison of screening by IIF (HEp 2) vs a new automated ANA/ENA screening (EliA) in defined patients
C. Gonzalez, J. M. Buitrago, M. Casas, F. Cava, B. Garcia, J. A. Navajo, W. Papisch, S. Valor
Pattern of humoral autoimmunity in patients with breast cancer
M. Volkmann, Y. Hajjar, J. Huober, D. Gaugel, J. Ludwig, S. Hänsel, G. Bastert, H. Zentgraf, D. Wallwiener, W. Fiehn
Nucleosome and dsDNA antibodies
A comparative study of the diagnostic efficiency of anti-dsDNA antibody tests in systemic lupus erythematosus
B. Schlüter, L. Kaucikaite, H. Schotte, P. Willeke, H. Becker, A. Dyong, J. Haier, R. Gellner, G. Bonsmann, M. Gaubitz
Clinical evaluation of a new dsDNA-RIA
R. Wöhrle, P. von Landenberg, M. Oppermann, K. Helmke, T. Witte
Detection of dsDNA antibodies in SLE: Efficiency of the automated EliA-immunoassay in comparison with non-automated systems
D. Kuhn, S. Kadler, E. Boehme, M. Linnemann
Performance of a new automated fluorescence immunoassay (EliATM dsDNA) for the follow-up of anti-ds DNA antibodies in SLE patients
A. Lakaf, C. Sapin, V. Moal, J. R. Harlé, M. Sanmarco
Detection of dsDNA antibodies in SLE: A case report based evaluation of discrepant results between the automated EliA immunoassay and an established non-automated assay
D. Kuhn, S. Kadler, E. Boehme, M. Linnemann
Comparison of two different methods for detection of dsDNA antibodies related to SLE patients at different disease status
M. Rodriguez-Mahou, F. J. López-Longo, J. L. Ruiz-Tiscar, E. F. dez-Cruz
Autoantibodies against nucleosomes are pathognomonic for SLE - A 2nd generation ELISA shows no reactivity with sera from scleroderma patients
W. Schlumberger, C. Daehnrich, W. Suer, S. Frahm, W. Stoecker
The benefit of anti-deoxyribonucleoprotein (anti-DNP) antibodies determination in the laboratory of clinical immunology
I. Lochman, L. Cebecauer, V. Novßk, H. Tomßckovß, A. Kloudovß, A. Lochmanovß
ENA antibodies
Evaluation of the detection of anti-dsDNA and -ENA antibodies by a new automated fluorescence immunoassay
M. López-Hoyos, H. López-Escribano, M. Peña, M. J. Bartolomé
Evaluation of EliATM screening and detection of antibodies directed against extractable nuclear antigens
E. Oris, C. Bunn, G. Godefridis, N. Kolbus, W. Papisch, X. Bossuyt
A new fluorescence immunoassay (EliA(tm) Sm) for the detection of anti-Sm antibodies
M. Mahler, R. C. Williams
A new LINE immunoassay for the detection of myositis-specific autoantibodies
C. Hentschel, J. Schulte-Pelkum, W. Schößler, F. Hiepe, R. Mierau, K. Conrad
Antibodies against SS-A can only be precisely detected using the native antigen: Results of a study using the EUROLINE-WB
W. Meyer, T. Scheper, K. Wilhelm, M. Jarzabek-Chorzelska, Z. Kolacinska-Strasz, W. Schlumberger, W. Stoecker
ANCA and GBM antibodies
Increased specificity for systemic vasculitis with capture ELISA for MPO-ANCA?
M. Carlsson, J. Wieslander, M. Segelmark
Evaluation of a new sensitive ELISA for the detection of PR3 Antibodies
M. Mahler, P. Höpfl, E. Mummert
Antineutrophil cytoplasmic antibodies in connective tissue diseases
G. Kirdaite, J. Dadonien, E. Redaitiene
Serum anti-glomerular basement membrane antibodies in patients with renopulmonary syndrome
D. Iordanescu, M. Cojocaru, I. Cojocaru, O. Neacsu